Bone density loss during treatment of chronic GVHD

Bone Marrow Transplantation

Volumn 17, Issue 3, 1996, Pages 395-400

  Stern, J M ^a   Chesnut III, C H ^b   Bruemmer, B ^a   Sullivan, K M ^a,b   Lenssen, P S ^a   Aker, S N ^a,b   Sanders, J ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bone density; Bone marrow transplantation; Human; Osteoporosis; Prednisone; Spine

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM ION; COLLAGEN; CYCLOSPORIN A; HYDROXYPROLINE; MAGNESIUM; PARATHYROID HORMONE; PREDNISONE; SEX HORMONE;

ABSORPTIOMETRY; ADULT; ARTICLE; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; HYDROXYPROLINE URINE LEVEL; IMMUNOSUPPRESSIVE TREATMENT; MAGNESIUM URINE LEVEL; MALE; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; DIET; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDNISONE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029928386     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nims J, Strom S. Late complications of bone marrow transplant recipients: nursing care issues. Semin Oncol Nurs 1988; 4: 47-54.
2. Lenssen PL, Sherry ME. Cheney CL et al. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 1990; 90: 835-842.
3. Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
4. Schutert MA, Sullivan KM. Schubert MM et al. Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 5: 425-430.
5. Sanders JE, Buckner CD, Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813-818.
6. Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med 1978; 92: 964-970.
7. Lindsay R, Aitken JM, Anderson JB et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976; 1: 1038-1041.
8. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980; 2: 1151-1154.
9. Hahn TJ. Corticosteroid-induced osteopenia. Arch Intern Med 1978; 138: 882-885.
10. Reid IR, Ibbertson HK, Evidence of decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 1987; 27: 200-204.
11. 3 in children receiving glucocorticoids. Lancet 1978; ii: 1123-1125.
12. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-364.
13. MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104: 648-651.
14. Doerr P, Pirke KM. Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab 1976; 43: 622-629.
15. Foresta C, Russa G, Mioni R et al. Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 1983; 15: 56-57.
16. Sanders JE, Buckner CD, Leonard JM et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983; 36: 252-255.
17. Gaurthier VJ, Leyka MB. Bone pain in transplant recipients responsive to calcium channel blockers. Ann Inern Med 1994; 121: 863-865.
18. Shils ME. Magnesium in health and disease. Ann Rev Nutr 1988; 8: 429-460.
19. June C. Thompson CB, Kennedy MS et al. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 1985; 39: 620-624.
20. Deluca HF. Vitamin D metabolism and function. Arch Intern Med 1978; 138: 836-847.
21. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. New Engl J Med 1995; 332: 305-311.
22. Carlson K. Simonsson B, Ljunghall S. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 1994; 55: 408-411.
23. Kelly PJ, Atkinson K. Ward TL et al. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 1990; 50: 881-883.
24. Sullivan KM, Witherspoon RP, Storb R et al. Alternating day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 1988; 72: 555-561.
25. Shane R, Rivas MDC, Silverberg SJ et al. Osteoporosis after cardiac transplant. Am J Med 1993; 94: 257-264.
26. Lee AH, Mull RL, Keenan GF et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994; 96: 35-41.
27. Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. New Engl J Med 1991; 325: 544-550.
28. Recommended Dietary Allowances (10th edn). National Academy Press: Washington DC, 1989, p 179.
29. Klein RG, Arnaud SB, Gallagher JC et al. Intestinal calcium absorption in exogenous hypercortisonism, J Clin Invest 1977; 60: 253-259.
30. Slovik DM, Adams JS. Neer RM et al. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. New Engl J Med 1981; 305: 372-374.
31. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. New Engl J Med 1992; 326: 357-362.
32. Gallagher JC, Goidgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled trial. Ann Intern Med 1990; 113: 649-655.
33. Ott SM, Chesnut CH III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989; 110: 267-274.
34. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis. New Engl J Med 1993; 328: 1747-1752.
35. Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. New Engl J Med 1990; 323: 73-79.
36. Overgaard K, Riis BJ, Christiansen C. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 1989; 30: 435-442.